Cansino Biologics Inc.

This study tests a new vaccine (PCV13i) to protect healthy infants from pneumococcal infections, which can cause pneumonia and meningitis. About 600 babies in Thailand will receive either the new vaccine or an existing one. Researchers will check if the new vaccine triggers a str…

This early-stage trial is testing a new vaccine that combines protection against diphtheria, tetanus, whooping cough, meningitis, and Hib into one shot. It involves 260 children aged 2 months to 6 years to check safety and immune response. The goal is to see if this combined vacc…

This early-stage study tests a new vaccine called Ad5-105K to see if it is safe and triggers an immune response against tuberculosis (TB). It involves 36 healthy adults aged 18 to 49 who have been exposed to TB but have not developed the disease. Participants receive either the v…